Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?
Furst
D E
DE
Arthritis Clinical Research Center, Virginia Mason Research Center, Seattle, WA 98101, USA.
D000483:Alleles; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D001175:Arthrography; D015331:Cohort Studies; D018849:Controlled Clinical Trials as Topic; D005938:Glucocorticoids / Q000627:therapeutic use; D006684:HLA-DR Antigens / Q000235:genetics; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D011241:Prednisone / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000032:analysis; D013583:Synovial Membrane / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D006684:HLA-DR Antigens; D012217:Rheumatoid Factor; D011241:Prednisone